**Core Concept**
The underlying condition described is **Restless Legs Syndrome (RLS)**, characterized by an irresistible urge to move the legs, usually due to uncomfortable sensations. This condition is often associated with **dopamine** pathway abnormalities.

**Why the Correct Answer is Right**
The drug of choice for RLS is typically a **dopamine agonist**, which helps in reducing the symptoms by mimicking the action of dopamine in the brain, thus providing relief from the uncomfortable sensations and the urge to move the legs.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because, although it might be used in some cases, it's not the first line of treatment.
**Option B:** Incorrect as it's not primarily used for RLS.
**Option C:** Incorrect because, while it might be considered in certain scenarios, it's not the preferred initial treatment.
**Option D:** This is the correct choice, as **Dopamine agonists** like ropinirole or pramipexole are considered first-line treatment for moderate to severe RLS.

**Clinical Pearl / High-Yield Fact**
Remember, RLS can be associated with **iron deficiency**, and checking **ferritin levels** is crucial in the management of these patients.

**Correct Answer:** D. Dopamine agonist.